Omega-3 fatty acids are important for maintaining a healthy cardiovascular system, brain, and eyes. However, the human body is unable to produce these fatty acids on its own. They have to be ingested, mainly by eating fish or swallowing capsules of fish oil. Conventional soft gel capsules are expensive to produce, and yet do little to protect their contents against aggressive gastric acid. This can lead to unpleasant fishy reflux.
For small tablets that are easy to swallow
The new AvailOm® powder can be directly pressed into compact tablets that are easy to swallow. A coating of EUDRAGUARD® polymers prevents fishy reflux. Additionally, a single, small tablet made from AvailOm® is equivalent to the same omega-3 fatty acid intake as two large fish oil capsules. As a result, it is a convenient way to meet health organizations’ recommendation of several hundred milligrams of EPA and DHA per day.
Powder with a very high concentration of omega-3 fatty acids
AvailOm® is a highly concentrated omega-3 lysine complex and contains the omega-3 fatty acids EPA and DHA that are essential for human health. “AvailOm® supplies omega-3 to the body directly in the form of free fatty acids. The bioavailability of free fatty acids is three to five times higher than in traditional fish oil capsules filled with liquid omega-3 ethyl esters,” explains Dr. Ludger Eilers, responsible for Advanced Food Ingredients within Evonik’s Health Care Business Line.
Product launch in the United States
By launching AvailOm®, Evonik is expanding its portfolio of advanced food ingredients, one of six defined innovation growth fields where Evonik is focusing its efforts. It includes natural dietary supplements with scientifically proven health benefits – plus formulation technologies that ensure APIs are released at the right location in the human body, at the right time.
AvailOm® has been FDA-approved for sale in the USA, and Evonik is pursuing registration in Europe and in other markets.